"Cipla values the relationship we have built with Accutest over the last years. Specifically, we value Accutest's demonstrated flexibility and adaptability in working within our environment while continuing to use its methodologies and best practices. We look forward to this relationship growing into a strong partnership in future."
Cipla Ltd.

“We began our association with Accutest in 2003 with a BA/BE study. Accutest team was always responsive and open to any minor / major suggestion made by us. The study received US FDA approval in Sept 2004 and the product was successfully launched in the US market. Accutest has earned our trust and we see this relationship continuing to grow.”
DR. Milind Joshi,
President - Regulatory Affairs & Quality Operations, J B Chemicals Pvt. Ltd.

"Accutest has established itself strongly in the BA/BE area with its expertise in clinical & analytical area. To us, their expertise in assay method development & validation & protocol designing have emerged as clear differentiating factors while choosing a CRO for a bioproject."
Abraham Moses,
Managing Director, Taro Pharmaceuticals India Pvt. Ltd.